INTRODUCTION
Many metabolic bone diseases characterized by high or low bone mass, such as osteogenesis imperfecta (1) , vitamin D-resistant rickets (2) , osteopetrosis (3) , and pyknodysostosis (4) , are known to have genetic bases. However, no investigations have been reported on the genetic factors in the etiology of senile or postmenopausal osteoporosis, a disease characterized by low bone mass and fractures.
In their review of osteoporosis, Newton-John and Morgan (5) have summarized the evidence that the A preliminary report of a portion of this work has been published (Smith, D. M., C. C. Johnston Received for publication 27 April 1973 and in revised form 9 July 1973. total mass of bone present determines to a great extent the risk of fracture and that the loss of bcne mass with age results in the increased frequency of fracture with age. It is appropriate, then, that both genetic and environmental factors that determine bone mass be examined in an attempt to gain some insight into the etiology of osteoporosis. Until recently, bone mass has been difficult to measure. However, precise in vivo estimates of bone mass can now be obtained by the photon absorption technique (6, 7) , and thus it is possible to measure this major manifestation of osteoporosis objectively, as a continuous variable, and to investigate genetic influences on this trait.
Theoretically, inheritance could affect the development of osteoporosis in at least two ways. Genetic factors could influence the amount of bone mass attained at maturity, and subjects with genetically determined low bone mass then might be more susceptible to develop osteoporosis after entering the period of agedependent bone loss. Alternatively, or in conjunction with the above, genetic factors could influence the rate of bone loss. Under the latter model, subjects with a genetically determined accelerated bone loss would be more susceptible to osteoporosis. The purpose of this study was to investigate the first model, namely, the influence of genetic factors on bone mass.
Twin studies provide an efficient technique for detecting the influence of genetic factors on quantitative traits in man (8, 9 twins (bw-Dz =0.0641+0.0054, bw-Dz = 0.0543+0.0067) were significantly (P < 0.01) higher than those for the MZ twins (bm-mz =0.0457+0.0022, bw-Mz = 0.0308± 0.0030). This probably reflects the slightly greater average age (12.1 yr) of the DZ twins compared to MIZ twins (11.3 yr); consequently, the DZ twin data are probably affected to a greater extent by the adolescent growth spurt. In the adult twins there was no significant change in either mass (bm -0.0038± 0.0040) or width (bw = 0.0014+0.0035) in the age range studied (Fig. 2) , and there was no significant difference in mean bone mass or width in MZ or DZ twins. Because of the significant age effect in the juvenile twins, the two sets of data were analyzed separately.
Effect of sex. As with the juvenile twins, the variances within DZ twins for mass -and width were significantly greater than those within MZ twins (P < 0.025 and P < 0.05), but the F ratios were not as large (Table I) highly correlated and adjustment of one trait for variation in the other had the effect of markedly reducing the residual evidence for genetic determination of the initial trait, as judged by the magnitude of the variance ratio. This finding is consistent with a high degree of commonality in the effects of the genetic factors that influence bone mass and width during the period of life when bone growth is not yet complete. In contrast, the variance ratios in adult twins were both increased by adjustment of the data for the other bone variable, suggesting that when growth and differentiation are complete, the effects of independent genetic determinants of bone width and mass can be detected. As an illustrative analogy, we might suppose that a mutant gene determining onychodystrophy has, along with many other genes, a general influence on limb bud development of the 10-mm embryo, but its specific effect would not be manifested until the nails begin to differentiate. In a similar manner, the individual expression of genes affecting bone mass, apart from bone size, may not occur until after bone growth is complete.
It is appropriate to relate the results of this investigation to the etiology of the disease osteoporosis. The disease is clinically significant only when fracture occurs, usually of the vertebral body, hip, or wrist. There are many factors that may increase the risk of fracture, but the total amount of bone mass present appears to be a major determinant of the risk of fracture (5) . Population surveys suggest that women developing fractures lose bone mass at a similar rate to age-matched controls (5, 21) . Hence the amount of bone mass at maturity would appear to be an important determinant of the amount of residual bone mass present in later years.
This study provides evidence that bone mass at maturity has significant genetic determinants. And it therefore seems reasonable to postulate that genetic factors, either by acting alone or by interacting with environmental variables known to influence mineral metabolism, may predispose to the development of osteoporosis.
